← All trials
NCT01310101
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2011
- Primary completion
- Feb 1, 2015
- Completion date
- Feb 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 33
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University Hospital BrnoLead sponsor
- Charles UniversityOverall official - principal investigator
- University Hospital BrnoOverall official - principal investigator
- University Hospital Hradec KraloveCollaborator
- Teaching Hospital Královské Vinohrady (FNKV)Collaborator
- Charles UniversityCollaborator
- University Hospital BrnoStudy director
- University Hospital BrnoReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.